Jerel did a 20min. presentation via webcast last night during the H.C. Wainwright 22nd Annual Global Investment Conference and the slides are available on the company's website marked as at 13 Sept 2020. Some updates were given on the current and following IND enabling studies. He mentioned 18 months twice as a timeframe for the beginning of human clinical trial enrolment.
Seems also H.C. Wainwright are the book-running manager for the new capital raising.
Hoyland, have you seen the presentation? What do you think? Do you still follow BNTC?
BLT Price at posting:
2.6¢ Sentiment: Hold Disclosure: Held
